Activist 13D/13G Filings - Ultragenyx Pharmaceutical Inc. (RARE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2022-02-03
4:41 pm
Sale		13GUltragenyx Pharmaceutical Inc.
RARE		BlackRock Inc.
BLK		3,484,652
5.1%		-1,802,824decrease
(-34.10%)		View
2021-10-26
4:44 pm
Sale		13DARCTURUS THERAPEUTICS HLDGS IN
ARCT		Ultragenyx Pharmaceutical Inc.
RARE		1,200,000
4.6%		-200,000decrease
(-14.29%)		View
2021-10-08
2:08 pm
Sale		13GUltragenyx Pharmaceutical Inc.
RARE		Capital Research Global Investors3,361,792
5%		-3,900,109decrease
(-53.71%)		View
2021-08-12
5:09 pm
Sale		13DARCTURUS THERAPEUTICS HLDGS IN
ARCT		Ultragenyx Pharmaceutical Inc.
RARE		1,400,000
5.3%		-800,000decrease
(-36.36%)		View
2021-02-16
4:04 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		Capital International Investors6,899,493
10.5%		304,831increase
(+4.62%)		View
2021-02-16
1:24 pm
Sale		13GUltragenyx Pharmaceutical Inc.
RARE		Capital World Investors3,129,724
4.7%		-107,571decrease
(-3.32%)		View
2021-02-16
1:16 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		Capital Research Global Investors7,261,901
11%		899,206increase
(+14.13%)		View
2021-02-16
12:23 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		PRICE T ROWE ASSOCIATES INC9,470,492
14.3%		2,851,572increase
(+43.08%)		View
2021-02-12
1:06 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		FEDERATED HERMES INC.
FHI		4,280,528
6.47%		1,308,520increase
(+44.03%)		View
2021-02-10
11:57 am
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		VANGUARD GROUP INC5,650,385
8.57%		797,226increase
(+16.43%)		View
2021-02-01
08:30 am
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		BlackRock Inc.
BLK		5,287,476
8%		554,392increase
(+11.71%)		View
2020-12-10
4:51 pm
Sale		13DARCTURUS THERAPEUTICS HLDGS IN
ARCT		Ultragenyx Pharmaceutical Inc.
RARE		2,200,000
9%		-800,000decrease
(-26.67%)		View
2020-11-06
4:16 pm
Purchase		13DSolid Biosciences Inc.
SLDB		Ultragenyx Pharmaceutical Inc.
RARE		7,825,797
14.5%		7,825,797increase
(New Position)		View
2020-05-22
5:21 pm
Purchase		13DARCTURUS THERAPEUTICS HLDGS IN
ARCT		Ultragenyx Pharmaceutical Inc.
RARE		3,000,000
14.6%		321,964increase
(+12.02%)		View
2020-05-11
1:21 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		PRICE T ROWE ASSOCIATES INC6,618,920
11.1%		2,127,151increase
(+47.36%)		View
2020-02-14
1:30 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		PRICE T ROWE ASSOCIATES INC4,491,769
7.7%		1,761,388increase
(+64.51%)		View
2020-02-14
12:07 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		Capital International Investors6,594,662
11.4%		1,292,075increase
(+24.37%)		View
2020-02-14
12:03 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		Capital Research Global Investors6,362,695
11%		506,540increase
(+8.65%)		View
2020-02-13
9:26 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		Capital World Investors3,237,295
5.6%		3,237,295increase
(New Position)		View
2020-02-13
3:34 pm
Purchase		13GUltragenyx Pharmaceutical Inc.
RARE		FEDERATED HERMES INC.
FHI		2,972,008
5.14%		2,972,008increase
(New Position)		View
Goto Prev, 0, 1, 2, Next